Literature DB >> 23093020

Diffusion and use of health technology assessment in policy making: what lessons for decentralised healthcare systems?

Oriana Ciani1, Rosanna Tarricone, Aleksandra Torbica.   

Abstract

OBJECTIVE: The Italian National Healthcare System (NHS) is one of the most decentralised systems since the devolution reform approved in 2001. HTA is spreading as an important tool for decision-making processes both at central and local levels. The aims of this study were to review the state of the health technology assessment (HTA) programmes in Italy - with a focus on regional and central initiatives - and to discuss consequences of a multi-level structure of HTA agencies in highly regionalised healthcare systems.
METHODS: Our method combined documentary review with interviews. We reviewed scientific literature about HTA's activities in decentralised systems, legislative and administrative documents from national as well as regional authorities. Semi-structured interviews were conducted with 18 key individuals associated with HTA both at the national and regional levels. Data on HTA programmes implemented or under development in nine regions were collected and analysed according to key principles for the improved conduct of health technology assessments for resource allocation decisions.
RESULTS: HTA is in the early stage of development in Italy, although with great heterogeneity across regions. The National Agency for Health Services has certainly contributed to HTA diffusion through supporting and training activities. However, the multi-level structure of HTA in Italy has not yet provided full coordination and harmonisation of practices and outcomes across the country, with a consequent exacerbate inequality of access to services and technologies.
CONCLUSIONS: There is probably need to rethink the multi-layer organizational framework of HTA in Italy by leveraging on current knowledge and efficient redistribution of activities across regions. We would advise for different jurisdictions playing different roles while achieving similar health outcomes for their patients, rather than jurisdictions aiming at doing exactly the same things resulting in unequal access to healthcare service provision.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23093020     DOI: 10.1016/j.healthpol.2012.09.017

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  6 in total

1.  Does the approach to economic evaluation in health care depend on culture, values, and institutional context?

Authors:  Aleksandra Torbica; Rosanna Tarricone; Michael Drummond
Journal:  Eur J Health Econ       Date:  2018-07

2.  Does health technology assessment compromise access to pharmaceuticals?

Authors:  Melanie Büssgen; Tom Stargardt
Journal:  Eur J Health Econ       Date:  2022-06-16

3.  The role of health technology assessment bodies in shaping drug development.

Authors:  Oriana Ciani; Claudio Jommi
Journal:  Drug Des Devel Ther       Date:  2014-11-10       Impact factor: 4.162

Review 4.  Priority-setting, the Indian way.

Authors:  Neethi V Rao; Laura Downey; Nishant Jain; Rama Baru; Francoise Cluzeau
Journal:  J Glob Health       Date:  2018-12       Impact factor: 4.413

5.  Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis.

Authors:  Carla Rognoni; Oriana Ciani; Silvia Sommariva; Irene Bargellini; Sherrie Bhoori; Roberto Cioni; Antonio Facciorusso; Rita Golfieri; Annagiulia Gramenzi; Vincenzo Mazzaferro; Cristina Mosconi; Francesca Ponziani; Rodolfo Sacco; Franco Trevisani; Rosanna Tarricone
Journal:  BMC Cancer       Date:  2018-07-05       Impact factor: 4.430

Review 6.  Need for HTA supported risk factor screening for hypertension and diabetes in Nepal: A systematic scoping review.

Authors:  Chiranjivi Adhikari; Rojana Dhakal; Lal Mani Adhikari; Bijaya Parajuli; Khem Raj Subedi; Yeshoda Aryal; Arjun Kumar Thapa; Komal Shah
Journal:  Front Cardiovasc Med       Date:  2022-08-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.